Appendix B: Sources of evidence considered by the Committee

Appendix B: Sources of evidence considered by the Committee

A. The assessment report for this appraisal was prepared by Peninsula Technology Assessment Group (PenTAG) Peninsula Medical School, Universities of Exeter and Plymouth with the Wessex Institute for Health Research and Development (WIHRD) University of Southampton.

  • Bond M, Mealing S, Anderson R et al. The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic mode, September 2007.

B. The following organisations accepted the invitation to participate in this appraisal. They were invited to comment on the draft scope, assessment report and the appraisal consultation document (ACD). Organisations listed in I and II were also invited to make written submissions and have the opportunity to appeal against the final appraisal determination.

I) Manufacturers/sponsors:

  • Advanced Bionics UK

  • Cochlear Europe

  • MED-EL UK

  • Neurelec

II) Professional/specialist and patient/carer groups:

  • Auditory Verbal UK

  • Cochlear Implanted Children's Support Group

  • Deafness Research UK (formerly Defeating Deafness)

  • DELTA

  • Ear Foundation

  • Link Centre for Deafened People

  • British Cochlear Implants Group

  • National Association of Deafened People

  • National Cochlear Implant Users Association

  • National Deaf Children's Society

  • Royal National Institute for the Deaf

  • Sense

  • British Academy of Audiology

  • British Association of Audiological Physicians

  • British Association of Otorhinolaryngologists – Head and Neck Surgeons

  • British Association of Teachers of the Deaf

  • Royal College of General Practitioners

  • Royal College of Nursing

  • Royal College of Paediatrics and Child Health

  • Royal College of Physicians

  • Royal College of Speech and Language Therapists

Others

  • Department of Health

  • Welsh Assembly Government

III) Commentator organisations (without the right of appeal):

  • Department of Health, Social Services and Public Safety for Northern Ireland

  • EUCOMED

  • NHS Quality Improvement Scotland

  • NHS Supply Chain

  • National Coordinating Centre for Health Technology Assessment

  • Peninsula Technology Assessment

  • University College London – Department of Phonetics and Linguistics

C. The following individuals were selected from clinical specialist and patient advocate nominations from the non-manufacturer/sponsor consultees and commentators. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on cochlear implants for severe to profound deafness in children and adults by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

  • Mr Christopher Raine, Clinical Specialist, Consultant ENT Surgeon, nominated by British Association of Otorhinolaryngologists – Head and Neck Surgeons

  • Mrs Louise Craddock, Clinical Specialist, Chair: British Cochlear Implant Group, nominated by British Academy of Audiology

  • Professor Mark Lutman, Clinical Specialist, Professor of Audiology, Institute of Sound and Vibration Research, nominated by British Academy of Audiology

  • Ms Tricia Kemp, Patient Expert; Chairperson, Cochlear Implanted Children's Support Group, nominated by National Cochlear Implant Users Association

  • Mr Nigel Williams, Patient Expert; Chairman, National Cochlear Implant Users Association, nominated by Cochlear Implanted Children's Support Group

  • National Institute for Health and Care Excellence (NICE)